Skip to main content
TipRanks
Go Ultimate75% OFF

Amneal Pharmaceuticals (2DT) Ownership - Who Owns Amneal Pharmaceuticals?

2 Followers

Amneal Pharmaceuticals (2DT) Ownership Overview

  • 36.76% Insiders
  • 11.00% Mutual Funds
  • 19.12% Other Institutional Investors
  • 16.37% ETFs
  • 16.75% Public Companies and Individual Investors

The ownership structure of Amneal Pharmaceuticals (DE:2DT) stock is a mix of institutional, retail, and individual investors. Approximately 46.49% of the company’s stock is owned by Institutional Investors, 36.76% is owned by Insiders, and 16.75% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Aug 13, 2026John Kiely$882,000
Aug 12, 2026Nikita Shah$2,563,517
Aug 12, 2026Jason B. Daly$3,771,050
May 11, 2026Deborah M. Autor$450,558

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Graham Capital Management, L.p.€1,139,342

Top Shareholders

DE:2DT top shareholders
Holder# of SharesType% HoldingValue
Tushar Bhikhubhai Patel61,341,678Insider17.61%1,299,032,715
Chintu Patel32,523,507Insider9.33%688,750,308
Chirag K. Patel29,044,624Insider8.34%615,078,002
BlackRock, Inc.26,877,188Institution7.71%569,178,210
Ishares20,708,543Institution5.94%438,544,815
Vanguard15,678,893Institution4.50%332,031,917
Vanguard Index Funds14,107,729Institution4.05%298,759,377
Invesco4,430,102Institution1.27%93,816,270
Spdr3,931,505Institution1.13%83,257,481
Dfa3,528,989Institution1.01%74,733,400

Top Mutual Fund Holders

DE:2DT top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds14,107,729Institution4.05%298,759,377
Dfa Investment Dimensions Group Inc2,842,778Institution0.82%60,201,510
Tiaa-cref Funds2,125,064Institution0.61%45,002,480
Fidelity Salem Street Trust2,107,263Institution0.60%44,625,509
Neuberger Berman Equity Funds1,908,642Institution0.55%40,419,312
Fidelity Concord Street Trust1,805,575Institution0.52%38,236,662
Vanguard Scottsdale Funds1,159,829Institution0.33%24,561,699
Columbia Funds Series Trust1,121,364Institution0.32%23,747,125
Vanguard Horizon Funds1,106,769Institution0.32%23,438,047
Vanguard Explorer Fund880,942Institution0.25%18,655,709

FAQ

Who Owns Amneal Pharmaceuticals (DE:2DT)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 46.49% of the company's stock is held by institutional investors, 36.76% is held by insiders, and 16.75% is held by public companies and individual investors.
What percentage of Amneal Pharmaceuticals (DE:2DT) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 46.49% of Amneal Pharmaceuticals (DE:2DT) stock is held by institutional investors: 11.00% by mutual funds, 16.37% by ETFs and 19.12% by other institutional investors.
What percentage of Amneal Pharmaceuticals (DE:2DT) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 16.75% of Amneal Pharmaceuticals (DE:2DT) stock is held by public companies and individual investors.
Who owns the most shares of Amneal Pharmaceuticals (DE:2DT)?
Tushar Bhikhubhai Patel owns the most shares of Amneal Pharmaceuticals (DE:2DT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.